Bull case
The bull case prices ALB at 4x on FY1 earnings, assuming continued execution and no meaningful deceleration in the core business.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where ALB stock could go
The bull case prices ALB at 4x on FY1 earnings, assuming continued execution and no meaningful deceleration in the core business.
At 3x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 11x multiple contraction could push ALB down roughly 84% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Albemarle is a leading global producer of specialty chemicals, primarily lithium compounds used in electric vehicle batteries and energy storage. The company generates most of its revenue from lithium sales—roughly 70%—with the remainder coming from bromine-based flame retardants and catalysts for refining and petrochemicals. Its key competitive advantage lies in owning low-cost lithium brine assets in Chile and hard rock resources in Australia, giving it scale and cost leadership in a supply-constrained market.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $0.11/$-0.83 | +113.3% | $1.3B/$1.3B | +4.6% |
| Q4 2025 | $-0.19/$-0.86 | +77.9% | $1.3B/$1.3B | +2.4% |
| Q1 2026 | $-0.53/$-0.42 | -26.8% | $1.4B/$1.3B | +6.0% |
| Q2 2026 | $2.95/$1.19 | +147.9% | $1.4B/$1.3B | +6.6% |
ALB beat EPS estimates in 3 of 4 tracked quarters. A strong delivery record supports forward estimate credibility.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $170 — implies +6.3% from today's price.
| Metric | ALB | S&P 500 | Basic Materials | 5Y Avg ALB |
|---|---|---|---|---|
| Forward PE | 13.2x | 18.8x-30% | 14.9x-12% | — |
| Trailing PE | -27.9x | 24.4x-214% | 23.6x-218% | 10.2x-375% |
| PEG Ratio | — | 1.66x | 1.23x | — |
| EV/EBITDA | 27.3x | 15.2x+79% | 11.0x+148% | 25.4x |
| Price/FCF | 27.3x | 20.7x+32% | 29.0x | 31.8x-14% |
| Price/Sales | 3.7x | 3.1x+19% | 1.9x+95% | 3.7x |
| Dividend Yield | 1.01% | 1.91% | 1.41% | 1.10% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolALB generates $577M in free cash flow at a 10.5% margin — returns 1.0% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~2.9 years to full repayment at current FCF run-rate
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated June 18, 2026
Solid-state batteries reducing lithium intensity or sodium-ion batteries capturing significant market share could drop Albemarle's 10-year Revenue CAGR to below +4%.
Albemarle faces cyclical risk from volatile lithium prices, as seen during the recent 'lithium winter' that caused prices to plummet from historic highs.
Despite long-term EV growth potential, Albemarle's current losses and high valuation pose risks to investor returns.
Advancements in alternative battery technologies could reduce reliance on lithium, negatively impacting Albemarle's core business.
Albemarle's heavy reliance on lithium and flame retardant chemicals exposes it to sector-specific downturns and regulatory changes.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated June 18, 2026
Albemarle operates advanced hard-rock and brine lithium resources, along with state-of-the-art conversion facilities, positioning it as a leader in lithium production.
The company's investment thesis remains strong due to regulatory tailwinds, despite recent market headwinds affecting stock performance.
Albemarle produces critical chemicals for medicines, disinfectants, and food/water safety, showcasing a resilient and diversified business model.
The company is a major developer of flame retardant technologies with a global production footprint across key markets.
Albemarle emphasizes transparency and sustainability in its operations, aligning with growing investor demand for responsible practices.
The bullish case for Albemarle hinges on the lithium cycle, though investors must assess how much is already priced in after recent rallies.
The Q1 2026 earnings report will test Albemarle's ability to translate the structural lithium deficit thesis into financial results.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
ALB ALB Albemarle Corporation | $18.9B | 13.2x | +5.7% | -4.2% | Hold | +30.8% |
SQM SQM Sociedad Química y Minera de Chile S.A. | $22.8B | 12.1x | +12.3% | 15.4% | Hold | +14.2% |
LAC LAC Lithium Americas Corp. | $976M | — | +10.0% | — | Hold | +60.2% |
ECL ECL Ecolab Inc. | $76.0B | 32.4x | +6.8% | 12.9% | Buy | +21.5% |
ASH ASH Ashland Inc. | $3.1B | 18.7x | -5.3% | -39.0% | Buy | -2.6% |
FMC FMC FMC Corporation | $1.4B | 6.8x | +2.7% | -72.9% | Hold | +39.4% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
ALB returns 1.0% total yield, led by a 1.01% dividend, raised 32 consecutive years.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.81 | — | — | — |
| 2025 | $1.62 | +0.6% | 0.0% | 1.1% |
| 2024 | $1.61 | +0.6% | 0.0% | 1.9% |
| 2023 | $1.60 | +1.3% | 0.0% | 1.1% |
| 2022 | $1.58 | +1.3% | 0.0% | 0.7% |
Common questions answered from live analyst data and company financials.
Albemarle Corporation (ALB) is rated Hold by Wall Street analysts as of 2026. Of 45 analysts covering the stock, 18 rate it Buy or Strong Buy, 21 rate it Hold, and 6 rate it Sell or Strong Sell. The consensus 12-month price target is $210, implying +30.8% from the current price of $160. The bear case scenario is $26 and the bull case is $54.
The Wall Street consensus price target for ALB is $210 based on 45 analyst estimates. The high-end target is $264 (+64.6% from today), and the low-end target is $153 (-4.6%). The base case model target is $41.
ALB trades at 13.2x times forward earnings. The stock currently trades at a discount to the broader market. Based on current multiples versus the peer group, the relative model signals fair versus peers. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for ALB in 2026 are: (1) Lithium demand disruption — Solid-state batteries reducing lithium intensity or sodium-ion batteries capturing significant market share could drop Albemarle's 10-year Revenue CAGR to below +4%. (2) Cyclical lithium pricing — Albemarle faces cyclical risk from volatile lithium prices, as seen during the recent 'lithium winter' that caused prices to plummet from historic highs. (3) Valuation concerns — Despite long-term EV growth potential, Albemarle's current losses and high valuation pose risks to investor returns. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates ALB will report consensus revenue of $5.8B (+5.7% year-over-year) and EPS of $3.46 (+276.4% year-over-year) for the upcoming fiscal year. The following year, analysts project $6.3B in revenue.
Albemarle Corporation is expected to report its next earnings on approximately 2026-07-29. Consensus expects EPS of $3.08 and revenue of $1.6B. Over recent quarters, ALB has beaten EPS estimates 58% of the time.
Albemarle Corporation (ALB) generated $577M in free cash flow over the trailing twelve months — a free cash flow margin of 10.5%. ALB returns capital to shareholders through dividends (1.0% yield) and share repurchases ($0 TTM).